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Background: Arterial media calcification (AMC) is highly prevalent and is a major cause of morbidity, mortality,
stroke and amputation in patients with diabetes mellitus (DM). Previous research suggests that advanced glycation
end products (AGEs) are responsible for vascular calcification in diabetic patients. The potential link between
oxidative stress and AGEs-induced vascular calcification, however, has not been examined.
Methods: Male Wistar rats received a high fat diet for 8 weeks followed by a single dose of streptozotocin to
induce DM (DM). Calcification was induced with Vitamin D3 and nicotine (VDN). We started VDN treatment at
1 week after the initial streptozotocin injection (DM+VDN). Age-matched rats were used as controls (CON).
Metabolic parameters, aortic calcium content, alkaline phosphatase (ALP) protein, malondialdehyde (MDA) content,
Cu/Zn superoxide dismutase (SOD) activity, aorta receptor for advanced glycation end products (RAGE) and aorta
AGEs levels were measured. In vitro, vascular smooth muscle cells (VSMCs) were cultured with AGEs in DMEM
containing 10 mmol·L-1 ß -glycerophosphate (ß-GP). Calcium content and ALP activity were used to identify
osteoblastic differentiation and mineralization. Western blots were used to examine protein expression of Cu/Zn
SOD, NADPH oxidase Nox1 and RAGE. In addition, the intracellular reactive oxygen species (ROS) generation was
evaluated using fluorescent techniques with dihydroethidine (DHE) method.
Results: The DM+VDN group showed a significant increase in aortic calcium content, levels of aorta AGEs, MDA
content, ALP protein levels and RAGE expression, although Cu/Zn SOD activity decreased significantly. In vitro,
enhanced Nox1, RAGE expression as well as the production of intracellular superoxide anions, and reduced
expression of Cu/Zn SOD induced by AGEs were attenuated by the anti-RAGE antibody or a ROS inhibitor.
Furthermore, the AGEs-stimulated ROS increase was also significantly inhibited by a SOD mimetic. Increased ALP
activity and calcium deposition were also inhibited markedly by the ROS inhibitor and the anti-RAGE antibody.
Conclusions: These results suggest that AGEs enhance vascular calcification partly through a RAGE/oxidative stress
pathway.
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Oxidative stressBackground
Vascular calcification is a form of heterotopic calcification,
that results in a decrease in elasticity and compliance
of the vessel walls, and was previously thought to be a
passive physicochemical process. Recent studies have
demonstrated that arterial calcification is highly prevalent
in patients with diabetes mellitus (DM) compared to the
general population and is associated with increased* Correspondence: liunf@seu.edu.cn
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reproduction in any medium, provided the ormorbidity, mortality, stroke and amputation rates [1-4].
Over recent years, several studies have revealed that vas-
cular calcification is an actively regulated process that is
similar to osteogenesis.
Advanced glycation end products (AGEs) derived from
reducing sugars reaction non-enzymatically with amino
groups of protein play an important role in the pathoge-
nesis of numerous diseases, including diabetic complica-
tions, atherosclerosis and aging. AGEs are formed at an
accelerated rate under diabetic states and during renal fai-
lure [5]. Recently, considerable evidences have suggested. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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AGEs have the ability to accelerate calcification in micro-
vascular pericytes, which could contribute to the develop-
ment of vascular calcification [6]. A study by Taki K et al.
showed a positive correlation between serum AGEs levels
and the severity of coronary artery calcification in hemo-
dialysis patients [7]. Alexi Baidoshvilia et al. found that in
DM patients, N (epsilon)-(carboxymethyl)lysine (CML), a
main antigenic structure of non-cross linking AGEs, accu-
mulated on calcification sites in degenerated aortic valves
and in internal thoracic arteries [8]. Indeed, previous data
showed that AGEs enhanced calcification in vascular
smooth muscle cells (VSMCs) through the receptor for
AGEs (RAGE) pathway [9,10]. Therefore, these results
suggest that AGEs are responsible for vascular calcifica-
tion in diabetic patients.
Vascular reactive oxygen species (ROS) contribute to
vascular functional and structural alterations. At the cellular
levels, ROS can result in the reduction of proliferation,
apoptosis, cell cycle arrest, and modulation of differenti-
ation [11-13]. Previous study suggested that hydrogen per-
oxide or xanthine/xanthine oxidase increased intracellular
oxidative stress and enhanced osteoblastic differentiation of
vascular cells, as demonstrated by their analysis of alkaline
phosphatase (ALP) activity and mineralization [14]. Indeed,
the engagement of RAGE with AGEs can induce oxidative
stress in VSMCs, thereby playing an important role in the
development and progression of many diseases [15]. The
potential link between oxidative stress and AGEs-induced
vascular calcification, however, has not been examined.
Given these findings, we hypothesized that AGEs ac-
celerated vascular calcification through the RAGE/oxida-
tive stress pathway in the present study.
Methods
Model preparation
The DM accompanied with arterial media calcification
(AMC) model was prepared as described previously [16].
All experiments were approved by the Animal Care and
Research Committee of Southeast University, and all ani-
mal procedures were performed in accordance with the
Guidelines of Animal Experiments from the Committee of
Medical Ethics, the National Health Department of China
(1998). Briefly, six-week old male Wistar rats (160–180 g,
Experimental Animal Center in Shanghai, China) were di-
vided into four groups. The first group was the DM group,
and was fed a high fat diet (HFD, 50% carbohydrates, 30%
fat (20% lard and 10% soybean oil), 11% protein, 2.5%
cholesterol, 6.5% fiber and other ingredients) (Animal
Center, Health Science Center, Southeast University) for
8 weeks, followed by a single dose of streptozotocin (STZ,
25 mg·kg-1, intraperitoneally, Sigma). Animals were con-
sidered to be diabetic when the blood glucose levels were
over 16.7 mmol·L-1. All of the rats were maintained on astandard chow for 1 week after the start of the STZ ad-
ministration. A portion of the diabetic rats were then
switched to treatment with a vehicle buffer (0.1 mol·L-1
sodium citrate buffer, pH 4.5) and a standard chow diet
(60% carbohydrates, 22% protein, 10% fat, 8% fiber and
other ingredients) (n = 10). For the second group (the DM
+VDN group), half of the diabetic rats were treated with a
single dose of vitamin D3 (300 000 U/kg, intramuscularly,
Sigma) and nicotine (25 mg·kg-1, 5 ml·kg-1, PO, Sigma) to
induce AMC (n = 10). Nicotine administration was re-
peated at 7 p.m. on the same day. For the third group (the
VDN group), 15-week old healthy rats were fed with a
standard chow diet and were administered with vitamin
D3 and nicotine (n = 10). Rats were then allowed to re-
cover for 8 weeks. The CON group included age-matched
rats that were only given a vehicle buffer and a standard
rat chow diet (n = 10). Please see Figure 1 for a depiction
of the treatment protocols.
Metabolic parameters and specimen preparation
Rats were starved for twelve hours before sacrifice. All rats
were anesthetized intraperitoneally with sodium pentobar-
bital (65 mg·kg-1). Blood samples were collected for meas-
urement of plasma variables. Measurement methods for
total cholesterol (TC), triglyceride (TG) concentrations,
plasma glucose and insulin were described previously [16].
The thoracic aortas were isolated. A portion of the tho-
racic aortas were frozen at −80°C for subsequent calcium
content and ALP protein expression.
Assessment of malondialdehyde content and superoxide
dismutase activity in aortas and serum samples
Prior to sacrificing the rats, serum samples were collected
in vials for analysis of malondialdehyde (MDA) content
and Cu/Zn superoxide dismutase (SOD) activity (Nanjing
Jiancheng Biotechnology Institute, China). After sacrifice,
a portion of the fresh aortas were collected in a buffer
solution and were subsequently homogenized. Next, the
homogenized tissue was centrifuged and supernatants
were collected for the analysis of MDA content and Cu/
Zn SOD activity. MDA content and Cu/Zn SOD activity
were measured as described previously [17]. Briefly, MDA
content was detected by the thiobarbituric acid method
with a maximal absorbance at 532 nm, and Cu/Zn SOD
activity was measured by the xanthine oxidase method
with an absorbance at 550 nm by spectrometry.
Determination of aorta AGEs
The levels of AGEs were analyzed by a fluorescent method.
Supernatants from aorta homogenates were measured on a
Hitachi 650–60 fluorescence spectrometer with excitation
and emission wavelengths of 380 nm and 452 nm, respect-
ively. Standard curves created with different concentrations
of AGE-BSA (0, 1, 5, 10, 50, 100 μg·mL-1) were used to










Figure 1 Schematic representation of chronic treatments in rats. Open bars represent a standard chow diet and gray bars represent a high
fat diet. The vertical dashed lines represent the injection of streptozotocin. The vertical solid lines represent the vitamin D3 and nicotine
treatment.
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1U of AGEs was equivalent to 1 μg·mL-1 of AGE-BSA.
Preparation of AGE-BSA
Briefly, bovine serum albumin (BSA) and D-glucose were
dissolved in sodium phosphate buffer (PBS). The final
concentrations were 50 mmol·L-1 of glucose and 5 g·L-1 of
BSA. The solution was sterilized by ultrafiltration, then
was incubated at 37°C for 90 days, and finally was dialyzed
against PBS. As a control, BSA was incubated in parallel
without D-glucose. No endotoxin was detectable in these
preparations.
Induction of calcification of rat VSMCs in vitro
VSMCs were isolated from one-week old Sprague–Dawley
rat thoracic aortas (Experimental Animal Centre, South-
east University, Nanjing, China) and cultured as described
previously [9]. Passages of 3–5 VSMCs were used for the
study. At sub-confluence, calcification of the cells was in-
duced in DMEM with 1% FCS in the presence of 10 mM
β-glycerophosphate (β-GP, Sigma, USA). This medium
was replaced twice a week. Cells were harvested for ana-
lysis at Day 3 of the treatment. In separate experiments,
sub-confluent VSMCs cultured in six-well culture plates
were pre-incubated with a neutralizing antibody to RAGE
(100 μg·mL-1, R&D) or 10 μmol·L-1diphenyleneiodonium
(DPI, Sigma), an inhibitor of ROS for 2 h. Next, AGE-BSA
was added to the medium containing 10 mmol·L-1 of β-
GP for 24 h prior to the measurement of gene and protein
expression, or for 72 h prior to the measurement of cal-
cium content. For all data shown, individual experiments
were repeated at least three times.
Quantification of calcium deposition
Analysis of calcium content in rat thoracic aortas was
performed according to previously described procedures
[18]. Briefly, portions of aortas were dried at 55°C and cal-
cium was extracted overnight at 4°C using 10% formic
acid. Cells were decalcified with 0.6 M HCl for 24 h. Thecalcium content in acid extracts was examined colorime-
trically by the O-Cresolphthalein Complexone method
(Calcium kit; Sigma) [10,19]. After decalcification, cells
were washed three times with PBS and solubilized with
0.1 M NaOH containing 0.1% SDS. A BCA assay kit
(Pierce) was used to determined protein concentration.
Aorta calcium content was expressed as μg/mg of dry tis-
sue, and cell calcium content was normalized to total pro-
tein content.Examination of ALP activity
Cellular proteins were solubilized with 1% Triton X-100 in
0.9% NaCl. After centrifugation, the supernatants were
assayed for ALP activity by using an ALP Assay Kit
(Sigma, USA) as described previously [20]. One unit was
defined as the activity producing 1 nmol of P-nitrophenol
for 30 min. The results were normalized to total cellular
protein levels as previously described [21].Western blot analysis
Total proteins of aortas and cells were extracted in the
RIPA lysis buffer (Beyotime, China). After centrifugation,
supernatants were collected for the determination of pro-
tein concentrations. Equal protein samples were loaded
on a 10% SDS–PAGE gel and transferred to PVDF mem-
branes (Bio-Rad). The membranes were blocked with 4%
milk-TBST, incubated overnight with the primary anti-
body, washed with TBST, and then incubated with the
secondary horseradish peroxidase-labeled antibody (Santa
Cruz, USA, dilution 1:1000). Immunodetection was
performed with the Enhanced Chemiluminescence Kit
(Amersham Biosciences, Piscataway, NJ). The following
antibodies were used: anti-RAGE monoclonal antibody
(diluted 1:250, R&D), anti-ALP monoclonal antibody
(diluted 1:500, Santa Cruz Biotechnology Inc), anti-Cu/Zn
SOD monoclonal antibody (diluted 1:500, Santa Cruz
Biotechnology Inc), and anti-Nox1monoclonal antibody
(diluted 1:500, Santa Cruz Biotechnology Inc).
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VSMCs calcification was induced with different concen-
trations of AGE-BSA for 2 h to analyze ROS. In separate
experiments, VSMCs cultured in 24-well culture plates
were pre-incubated with a neutralizing antibody to RAGE,
DPI, or 100 μmol·L-1 tempol ( a SOD mimetic, R&D) for
2 h, followed by treatment with 100 mg·L-1AGE-BSA for
another 2 h to determine ROS levels. ROS generation was
evaluated using the fluorescent technique with dihydro-
ethidine (DHE, Genmed Scientifics Inc. USA) according
to the manufacturer’s instructions. VSMCs were incubated
with DHE (diluted 1:100 with dilution reagents) for
20 min at 37°C in the dark and were then washed with
PBS. Fluorescence was determined using a microscope
(Nikon, Japan) at excitation and emission wavelengths of
540 nm and 590 nm, respectively. Fluorescence intensity
was semi-quantitatively analyzed by NIS-Elements F 3.0.
Immunohistochemistry
Immunohistochemistry was performed to detect RAGE.
Briefly, after dewaxing and hydration of sections, tissue
slides were treated with 3% H2O2 for 10 min, then were
incubated with the primary antibody against RAGE (R&D,
1:20) overnight at 4°C, followed by incubation with the
secondary antibody conjugated to horseradish peroxidase.
The antibodies were detected by the diaminobenzidine
method which produces a brown color. Adjacent sections
treated with non-immune IgG provided controls for anti-
body specificity. The area of the aorta with brown staining
was quantified. The analysis was performed blindly by two
examiners for the same slides.
Von kossa staining
The presence of mineral deposits was confirmed by Von
kossa staining. Paraffin sections from aortas were dewaxed
and hydrated. The slices were immersed in 1% silver ni-
trate for 30 min under an intense sunbeam, and were then
washed 3 times with deionized water. Subsequently, 5%
sodium thiosulfate (Sigma) was added for 5 min to remove
un-reacted silver. The calcium phosphate salts were visu-
alized as a black staining.
Statistical analysis
Data were presented as the mean ± SD. A one-way
ANOVA followed by a post hoctest and chi-square test
were performed for statistical comparisons. P< 0.05 was
considered to be significant.
Results
Metabolic parameters
After completion of 8 weeks of high fat diet feeding, serum
triglycerides and cholesterol concentration measurements
showed a significant difference between HFD rats and
CON rats (TG: 2.25±0.25 mmol·L-1vs 0.48±0.05 mmol·L-1,TC: 6.22±0.57 mmol·L-1vs 2.74±0.32 mmol·L-1, respect-
ively, p<0.05). At the end of the experiment, as shown in
Table 1, these diabetic rats showed weight loss, low
insulinemia and high glycemia. The addition of VDN accel-
erated this tendency in diabetic rats. Weight loss was not
observed in the VDN group. In addition, no significant dif-
ferences were detected regarding serum triglycerides and
cholesterol concentrations among all groups, suggesting
that VDN treatment alone did not affect serum lipids and
that normal lipid metabolism in the DM treatment groups
maybe associate with weight loss.
Medial calcification in thoracic aortas
Three weeks of VDN treatment did not produce calcifica-
tion in the aorta (data not shown). Minimal calcification
was expected in the aorta media when rats were treated
with VDN for four weeks. The Von kossa staining revealed
extensive calcium deposits in the arterial media of the DM
+VDN group (Figure 2A).To study the acceleration of vas-
cular calcification, rats were sacrificed four weeks after
VDN treatment. As shown in Figure 2B, only the DM and
VDN treatments did not cause a significant elevation of
calcium content in the aortas. Calcium content in the aor-
tas of DM+VDN rats, however, were significantly in-
creased (p<0.05). Aorta ALP protein expression was
significantly increased in both the VDN group and DM
+VDN group compared to the DM and control groups.
Moreover, aorta ALP protein expression in the DM+VDN
group was significantly higher than those found in the
VDN group (p<0.05, Figure 2C).
SOD activity and MDA content in serum samples and
thoracic aortas
Compared to the CON group, Cu/Zn SOD activity and
MDA content in aortas and serum samples of VDN group
(p>0.05, Figure 3) showed no significant differences. In
the VDN+DM and DM groups, when compared to the
CON and VDN groups (p<0.05, Figure 3), the production
of MDA in aortas and serum samples was significantly in-
creased, and Cu/Zn SOD activity was decreased compared
to the DM and VDN groups (p<0.05, Figure 3). Moreover,
changes of SOD activity and MDA content were more sig-
nificant in the DM+VDN group than in the DM group
(p<0.05, Figure 3).
Aorta AGEs levels and RAGE expression
Immunohistochemical staining for RAGE in aortas re-
vealed that RAGE appeared in the media. As shown in
Figure 4, compared to the control group, RAGE expres-
sion increased significantly in the DM and DM+VDN
groups (p<0.05). Moreover, RAGE expression was more
significant in the DM+VDN group than in the DM group
(p<0.05). However, an increase of RAGE expression in the
Table 1 Metabolic parameters in the experimental groups
Groups n Weight (g) Glu (mmol·L-1) Ins (ng·mL-1) Cho (mmol·L-1) TG (mmol·L-1) HbA1c(%)
CON 10 530 ± 20 5.53 ± 0.26 0.75 ± 0.12 2.21 ± 0.19 0.47 ± 0.05 7.1 ± 1.1
DM 10 470 ± 15*# 17.21 ± 0.95*# 0.58 ± 0.11*# 2.09 ± 0.22 0.51 ± 0.11 16.5 ± 2.7*#
VDN 10 521 ± 16 5.26 ± 0.46 0.69 ± 0.13 2.12 ± 0.21 0.42 ± 0.03 8.2 ± 1.3
DM+VDN 10 422 ± 17*# 25.61 ± 1.92*# 0.32 ± 0.05*# 1.99 ± 0.18 0.49 ± 0.04 23.4 ± 3.5*#
*p< 0.05 vs without VDN. #p< 0.05 vs VDN group. Cho, cholesterol. Glu, glucose. Ins, insulin. TG, triglyceride.
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the pattern of RAGE expression in the different groups.
Effect of AGEs on redox signaling
To understand the mechanism by which AGEs accelerate
vascular calcification, in vivo, we further examined













































Figure 2 Diabetes accelerated rat aorta calcification. (A) Von
kossa staining (black calcium particles, ×200). (B) Aorta calcium
content. (C) ALP protein expression. Values represent the mean ±
SD (n=10). * p<0.05 versus control group, # p<0.05 versus
VDN group.and destruction was involved in this process. As shown in
Figure 5C and Figure 5A, AGEs significantly increased
the levels of Nox1 protein and ALP activity in a dose-
dependent manner in cultured VSMCs after 72 h of calci-
fication induction (p<0.05). In addition, ROS production
was also significantly increased compared to the control
group (Figure 5B, p<0.05), whereas, Cu/Zn SOD protein
expression was markedly suppressed (Figure 5C, p<0.05).
Effect of RAGE blockade and ROS inhibition on
calcification and redox signaling in VSMCs
Pretreatment of VSMCs with the neutralizing antibody
to RAGE or DPI for 2 h reduced the increase of ALP ac-
tivity induced by AGEs after a 24 h cultivation period
(Figure 6A, p<0.05). Figure 6B shows the effect of the
RAGE blockade or DPI inhibition on calcium content,
indicating that the anti-RAGE antibody and DPI signifi-
cantly decreased calcium content following induction by
100 mg·L-1 of AGEs after a 72 h incubation. The in-
creased ROS generation induced by AGEs was signifi-
cantly eliminated by 2 h-treatment with DPI, anti-RAGE
or tempol (Figure 6C, p<0.05). RAGE and Nox1 protein
expression induced by AGEs were significantly inhibited,
however, Cu/Zn SOD protein expression increased sig-
nificantly (Figure 6D, p<0.05).
Discussion
Although vascular calcification is a strong predictor of
diabetes-related cardiovascular events [4], the underlying
mechanism of this observation remains unclear. Elucida-
tion of these mechanisms is important for the establish-
ment of new therapies to prevent vascular calcification.
Increasing evidence has suggested that vascular calcifica-
tion is an active and regulated process. Many cardiovascu-
lar factors, including inorganic phosphate and oxidized
LDL, accelerate vascular calcification [22-24]. AGEs are
among the factors responsible for diabetic vascular com-
plications [25,26], and RAGE is the most well character-
ized receptor for AGEs [27]. AGEs are formed at an
accelerated rate under diabetic states. In the present study,
we first selected a rat model of diabetes that shared simi-
larities with type 2 diabetes in human population. In our
model, the administration of the HFD induced an insulin
resistance state (data was not shown), which is consistent

























































Figure 4 The levels of aorta AGEs and aorta RAGE protein
expression increased in DM+VDN rats. (A) Aorta AGEs levels.
(B) Aorta RAGE expression (×200). Values represent the mean ± SD.
L: Lumen, M: Media, A: Adventitia.* p<0.05 versus control group, #
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Aorta SOD Serum SOD
B
A
Figure 3 MDA content and Cu/Zn SOD activity in aorta and
serum. (A) Rat aorta and serum SOD activity. (B) Rat aorta and
serum MDA content. Values represent the mean ± SD (n=10). *
p<0.05 versus control group, # p<0.05 versus VDN and DM group.
Wei et al. BMC Cardiovascular Disorders 2013, 13:13 Page 6 of 10
http://www.biomedcentral.com/1471-2261/13/13rats [18,28]. The administration of a low dose of STZ
(25 mg/kg) aimed at slightly reducing the β cell function
to obtain hyperglycemia, since a 30 mg/kg dose of STZ
administration insulin deficiency results in insulin defi-
ciency and diabetes could be thought as type 1 [29].
In our previous study, we demonstrated that AGEs ac-
celerated vascular calcification by promoting osteoblast-
like differentiation of rat VSMCs via the RAGE pathway
[9]. Tanikawa T et al. reported similar findings [10]. The
present study demonstrates that the degree of arterial cal-
cification, the levels of aorta AGEs and RAGE expression
are significantly increased in DM+VDN rats (Figure 2 and
Figure 4). In addition, hyperglycemia was more prominent
in DM+VDN rats (Table 1). Although high glucose levels
promoted calcification of VSMCs [30], other studies fur-
ther supported the pathological role of AGEs in vascular
calcification. Tanikawa T et al. found that AGEs induced
calcification of vascular smooth muscle cells irrespective
of glucose concentration. Furthermore, calcification of
VSMCs induced by diabetic serum was inhibited by RAGE
blockade [10]. The relationship between cardiovascular
mortality of patients with diabetes and vascular calcifica-
tion was observed regardless of glycemic control and
known duration of diabetes [31]. Additionally, our datadid not show an increase in serum lipid levels among all
groups [16]. This apparently normal lipid metabolism
should not influence our results, as medial calcification is
not associated with lipid deposition. These results suggest
that AGEs might accelerate vascular calcification that is ini-
tiated by VDN and that AGEs are among the factors
responsible for vascular calcification in diabetes. However,
themechanism remains unknown in these previous studies.
Oxidative stress results from an increase in the produc-
tion of ROS, notably superoxide anions. The ROS act as
Figure 5 Effects of AGEs on ALP activity, superoxide production, and protein expression of Nox1 and Cu/Zn SOD on calcification of rat
VSMCs induced by β-GP. VSMCs were treated with various concentrations of AGEs (BSA, 50, 100, 200, 400 μg·mL-1) for 24 h. (A) ALP activity. (B)
Cellular levels of superoxide. (C) Protein expression of Nox1 and Cu/Zn SOD. These results were obtained from at least three independent
measurements. * p<0.05 versus BSA, # p<0.05 versus 100 μg·mL-1AGE-BSA.
Wei et al. BMC Cardiovascular Disorders 2013, 13:13 Page 7 of 10
http://www.biomedcentral.com/1471-2261/13/13second messengers and play an important role in the de-
velopment of diabetic vascular complications. AGEs
exaggerate the vascular damage that is subjected to in-
creased oxidative stress [32,33]. In addition, several re-
searches have suggested that oxidative stress plays a role
in vascular calcification. F. T. Tang et al. reported that
hypercholesterolemia accelerated vascular calcification
induced by excessive vitamin D via oxidative stress [34].
H2O2 promotes a phenotypic switch of VSMC from a
contractile to an osteogenic phenotype [35]. We therefore
hypothesized that oxidative stress may be the downstream
signal of AGE/RAGE accelerating calcification.
To investigate the role of oxidative stress in the rat
vascular calcification model, we measured MDA, which
serves as a lipid peroxidation marker and has been vali-
dated in several mouse models regarding oxidative stress.
We also examined SOD, which acts as the first line ofdefense against oxygen free radical-mediated damage by
catalyzing the dismutation of superoxide anions. In the
present study, we found that serum and aorta MDA con-
tent in DM+VDN rats increased significantly, however,
Cu/Zn SOD activity decreased markedly (Figure 3). To-
gether with increased aorta AGEs levels and RAGE ex-
pression in DM+VDN rats (Figure 4), our findings suggest
that at least one mechanism by which AGEs augment
vascular calcification involves promoting oxidative stress,
although many factors are clearly involved in the initiation
and progression of vascular calcification.
Next, we examined markers of oxidative stress in cul-
tured VSMCs. Consistent with previous studies in various
cell lines, our results also showed AGEs linked to en-
hanced oxidative stress in calcified VSMCs. We found a
marked increase in intracellular O2
- production in calcified
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Figure 6 Effect of RAGE blockade and ROS inhibition on osteoblastic differentiation and oxidative stress signaling pathways in rat
VSMCs calcification accelerated by AGEs. (A) ALP activity. (B) Calcium content. (C) ROS generation (×200). (D) Nox1, RAGE and Cu/Zn SOD
protein expression. Data were from three separate experiments. * p<0.05 vs BSA, # p<0.05 vs AGE-BSA.
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considerably (Figure 6C), and attenuated the calcification
that we observed in cultured VSMCs (Figure 6A 6B).
These results showed that ROS is involved in AGEs-
induced calcification. NADPH oxidase is the major source
of ROS production. There are five known forms of
NADPH oxidase, which are classified by the presence of
different Nox isoforms (Nox1-5) [36]. Previously, it has
been shown that agonist-induced ROS production in
VSMCs is mediated by Nox1 [37] and AGEs accelerates
dysfunction in VSMCs, particularly under conditions ofincreased Nox1 expression [38,39]. The above-mentioned
observations and studies suggested that Nox1 could be a
mediator of ROS production in VSMCs calcification in-
duced by AGEs. We therefore sought to investigate Nox1
expression in calcified VSMCs induced by AGEs. Our re-
sults showed that Nox1 expression increased (Figure 5C).
And ROS inhibition with DPI and RAGE blockade mark-
edly reduced Nox1 expression (Figure 6D). These findings
support that AGEs-induced calcification in VSMCs is me-
diated by oxidative stress, at least in part, involving Nox1.
Of course, other Nox isoforms maybe also play a role in
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ther research about the role of all Noxs in vascular calcifi-
cation induced by AGEs is necessary in the future.
Conversely, SOD is a primary cellular defense against
ROS, and the predominant activity of SOD in peripheral
vessels is attributed to Cu/Zn SOD [40]. We observed a
significant reduction in Cu/Zn SOD expression (Figure 5C)
accompanied with a marked increase in cellular O2- pro-
duction in calcified VSMCs induced by AGEs (Figure 5B).
And ROS inhibition with DPI and RAGE blockade in-
creased markedly Cu/Zn SOD expression (Figure 6D).
These results show that vascular calcification induced by
AGEs is mediated by oxidative stress. Further supporting
evidence comes from our findings that SOD mimetic
inhibited ROS production induced by AGEs (Figure 6C).
Limitations of the study
In vivo, our data indicated that AGE/RAGE/oxidative
stress axis was associated with diabetic vascular calcifica-
tion. We further confirmed this effect of AGEs on calcifica-
tion and the mechanisms involved in vascular calcification
in vitro. There is no direct in vivo evidence that AGEs
accelerate vascular calcification or that oxidative stress me-
diates this effect. We did not investigate other Nox and
SOD isoforms in addition to Nox1 and Cu/Zn SOD. Nox2
and Nox4 have recently been implicated in superoxides.
Mitochondrial derived ROS may be involved in vascular
calcification accelerated by AGEs.
Conclusion
In summary, this study demonstrates that AGEs might
enhance vascular calcification induced by Vitamin D3
and nicotine in rats via an oxidative stress pathway. This
hypothesis is further supported by in vitro results show-
ing that blockage of RAGE and ROS inhibition attenu-
ates the acceleration of rat VSMCs calcification by
AGEs. These results indicate that inhibition of the AGE/
RAGE/oxidative stress pathway could potentially be an
effective therapy for the prevention of vascular calcifica-
tion in diabetic patients.
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